Active substanceSulfacetamideSulfacetamide
Similar drugsTo uncover
  • Sulfacetamide
    drops d / eye 
    ESKOM NPK, OAO     Russia
  • Sulfacil sodium
    drops d / eye 
    UPDATE OF PFC, CJSC     Russia
  • Sulfacil sodium (Albucide)
    drops d / eye 
    LEKKO, ZAO     Russia
  • Sulfacil sodium-Vial
    drops d / eye 
    ALVILS, LTD.     Russia
  • Sulfacil sodium-DIA
    drops d / eye 
  • Sulfacil sodium-SOLOfarm
    drops d / eye 
    GROTEKS, LLC     Russia
  • Sulfacil sodium
    drops d / eye 
  • Sulfacil sodium
    drops d / eye 
    FARMAK, PAO     Ukraine
  • Sulfacil sodium
    drops d / eye 
    SYNTHESIS, OJSC     Russia
  • Sulfacil sodium
    drops d / eye 
    VIPS-MED, LLC     Russia
  • Sulfacil sodium
    drops d / eye 
  • Sulfacil sodium
    drops d / eye 
    YUZHFARM, LLC     Russia
  • Sulfacil sodium
    drops d / eye 
  • Sulfacil-sodium-MEZ
    drops d / eye 
  • Dosage form: & nbspEye drops.
    Composition:
    Composition per ml:
    active substance: sodium sulfacetamide - 200 mg;
    excipients: sodium thiosulfate - 1.5 mg, 1 M solution of hydrochloric acid - to a pH of 7.7 to 8.7, water for injection - up to 1 ml.
    Description:Transparent colorless or slightly colored liquid.
    Pharmacotherapeutic group:Antimicrobial agent - sulfonamide.
    ATX: & nbsp

    A.07.A.B   Sulfonamides

    Pharmacodynamics:
    Antimicrobial bacteriostatic agent, sulfanilamide. The mechanism of action is due to competitive antagonism with paraaminobenzoic acid (PABA), inhibition of dihydropteroate synthetase, a violation of the synthesis of tetrahydrofolic acid necessary for the synthesis of purines and pyrimidines.
    Active against gram-positive and gram-negative cocci, Escherichia coli, Shigella spp., Vibrio cholerae, Clostridium perfringens, Bacillus anthracis, Corynebacterium diphtheriae, Yersinia pestis, Chlamydia spp., Actinomyces israelii, Toxoplasma gondii.
    Pharmacokinetics:Penetrates the tissues and fluid eyes. Absorbed into the systemic bloodstream through an inflamed conjunctiva. With topical application, the maximum concentration of sulfonamides in the cornea (about 3 mg / ml), the anterior chamber humidity (about 0.5 mg / ml) and the iris (about 0.1 mg / ml) is achieved in the first 30 minutes after application. Some amount (less than 0.5 mg / ml) is stored in the tissues of the eyeball for 3-4 hours. If the epithelium of the cornea is damaged, the penetration of sulfonamides is enhanced.
    Indications:Conjunctivitis, blepharitis, purulent corneal ulcer, prevention and treatment of blenarus in newborns, gonorrhea and chlamydia eye diseases in adults.
    Contraindications:Hypersensitivity.
    Pregnancy and lactation:It is possible to use sulfacetamide to treat pregnant and lactating mothers as prescribed by the doctor if the intended benefit to the mother exceeds the potential risk to the fetus and the baby.
    Dosing and Administration:Locally, instill 1-2 drops in each conjunctival sac 4-6 times a day. For the prevention of blennery in newborns - 2 drops in each conjunctival sac immediately after birth and 2 drops - after 2 hours.
    Side effects:Burning, lacrimation, itching, itching in the eyes, allergic reactions.
    Interaction:The combined use with procaine and tetracaine reduces the bacteriostatic effect. Incompatible with the salts of silver.
    Special instructions:Patients who are hypersensitive to furosemide, thiazide diuretics, sulfonyl urea or inhibitors of carbonic anhydrase may have increased sensitivity to sulfacetamide.
    Form release / dosage:Eye drops 20%.
    Packaging:5 ml or 10 ml in the bottles-dropper polymer. Each vial with instructions for use is placed in a pack of cardboard. 50 bottles are placed in boxes of cardboard with the application of 5 instructions for use for delivery to hospitals.
    Storage conditions:
    In the dark place at a temperature of 15 to 25 ° C. Keep out of the reach of children.

    Shelf life:
    2 years.
    After opening the vial, use within 1 month. Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N003555 / 01
    Date of registration:14.05.2009
    The owner of the registration certificate:SYNTHESIS, OJSC SYNTHESIS, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp03.09.2015
    Illustrated instructions
      Instructions
      Up